|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2009-9-4
|
|
pubmed:abstractText |
Suicidal ideation is an uncommon but worrisome symptom than can emerge during antidepressant treatment. We have described earlier the association between treatment-emergent suicidal ideation (TESI) and markers in genes encoding glutamate receptor subunits GRIK2 and GRIA3. The present genome-wide association study was conducted to identify additional genetic markers associated with TESI that may help identify individuals at high risk who may benefit from closer monitoring, alternative treatments, and/or specialty care.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1744-6872
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
666-74
|
|
pubmed:dateRevised |
2011-9-29
|
|
pubmed:meshHeading |
pubmed-meshheading:19724244-Adolescent,
pubmed-meshheading:19724244-Adult,
pubmed-meshheading:19724244-Aged,
pubmed-meshheading:19724244-Citalopram,
pubmed-meshheading:19724244-Depressive Disorder, Major,
pubmed-meshheading:19724244-Genetic Markers,
pubmed-meshheading:19724244-Genome-Wide Association Study,
pubmed-meshheading:19724244-Genotype,
pubmed-meshheading:19724244-Humans,
pubmed-meshheading:19724244-Middle Aged,
pubmed-meshheading:19724244-Outpatients,
pubmed-meshheading:19724244-Pharmacogenetics,
pubmed-meshheading:19724244-Phenotype,
pubmed-meshheading:19724244-Polymorphism, Single Nucleotide,
pubmed-meshheading:19724244-Retrospective Studies,
pubmed-meshheading:19724244-Serotonin Uptake Inhibitors,
pubmed-meshheading:19724244-Suicide,
pubmed-meshheading:19724244-Treatment Outcome,
pubmed-meshheading:19724244-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients.
|
|
pubmed:affiliation |
Genetic Basis of Mood and Anxiety Disorders Unit, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA. gonzalo.laje@nih.gov
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural,
Research Support, N.I.H., Intramural
|
